Functional Medicine · Hormonal Health

The Journal

by Dr. Natasha Ryan, ND

Perimenopause · Mood & Anxiety

Perimenopause Anxiety vs. Generalized Anxiety Disorder: How to Tell the Difference

She was told it was anxiety, and she was handed a prescription. Nobody asked about her cycle, her sleep, or whether it had a pattern. Or the reverse happened: she has had an anxiety disorder for years, and she has been told her worsening symptoms are just perimenopause.

Both mistakes happen. In one industry survey, 22% of women aged 40 to 49 said a provider had attributed their perimenopause symptoms to anxiety. This article is about how to tell what you are dealing with, and why the answer is often "both."

What the research shows

The Study of Women's Health Across the Nation (SWAN) followed 2,956 women who were 42 to 52 at the start, for ten years. Among women with low anxiety at baseline, the odds of high anxiety were about 1.6 times higher in early perimenopause, late perimenopause, and postmenopause than before menopause. Women who already had high anxiety stayed high throughout, and their risk did not differ by stage.

That fits the clinical picture. For women with no prior anxiety, the menopause transition looks like a window of new vulnerability. For women who were already anxious, perimenopause may not be the cause.

The picture is not uniform. Some studies have not found a consistent rise in anxiety by menopausal stage. Hot flashes and night sweats, however, have been consistently associated with anxiety, which makes it hard to separate the two.

A second SWAN analysis found that anxiety symptoms emerging during the transition predicted later major depressive episodes, with about 1.5 times the odds at the next annual visit. That is one reason new anxiety in midlife should be taken seriously rather than dismissed.

On mechanism, progesterone is converted to allopregnanolone, which acts on the same brain receptors as anti-anxiety medications. As progesterone falls with less frequent ovulation, that calming signal drops. A study of late perimenopause and early postmenopause found that allopregnanolone levels were related to depressive symptoms. More on this in Anxious Annie.

Clues it may be perimenopause

  • It is new, beginning in your late 30s or 40s with no real history of anxiety.
  • It follows your cycle. It is worse in the week or so before your period and eases when bleeding starts.
  • It comes with other changes: waking at 3 AM, night sweats, changing cycles, or a pounding heart.
  • It is physical more than mental. You feel a surge of adrenaline, internal shakiness, or dread without a clear thought behind it.
  • Irritability or rage is a big part of it, out of proportion to what set it off, and it feels unlike you.

Clues it may be an anxiety disorder

  • Anxiety on and off since your teens or twenties.
  • Persistent, hard-to-control worry about many things, on most days, for at least six months. That is the clinical threshold for generalized anxiety disorder.
  • No relationship to your cycle.
  • A family history of anxiety.

Many women fit both lists. Perimenopause can make an existing anxiety disorder much harder to control, which is the pattern the SWAN data point to for women who were already anxious.

What else to check

Several things cause anxiety that are easy to test and fix: an overactive thyroid, low iron, low B12, blood sugar swings, sleep apnea, and too much caffeine or alcohol. Alcohol acts on the same calming receptors and rebounds in the early morning hours. ADHD can also look like anxiety in midlife, especially when it was never diagnosed. See how to tell these apart.

What treatment has evidence

This is not either-or, and nobody should withhold treatment for anxiety while waiting to see whether it is hormonal.

  • Therapy and medication work. Cognitive behavioral therapy and SSRIs or SNRIs are effective for anxiety whether or not hormones are involved. If anxiety is interfering with work, sleep, or relationships, or you are having panic attacks, treating it is appropriate. Some of these medications also reduce hot flashes.
  • Hormone therapy may help in some women, but it is not a standalone anxiety treatment. Systematic reviews presented at The Menopause Society's 2025 meeting found that estrogen-based therapy did not consistently reduce anxiety or depression, though effects varied with whether hot flashes were present. A European expert statement concluded that hormone therapy may improve depressive symptoms in perimenopausal women, especially those with hot flashes, though it is not approved for that purpose. My read is that it makes the most sense when hot flashes and poor sleep are driving the mood symptoms.
  • Fix sleep. Poor sleep makes anxiety worse, and the 3 AM waking pattern has its own article: Waking at 3 AM.
  • Cut alcohol and trim caffeine for a few weeks and see how you feel.
  • Keep blood sugar steady with protein at each meal, and lift weights regularly. Both have good evidence for mood and anxiety.
  • Calm the stress response. The nervous system article covers what works in practice.
  • Consider magnesium glycinate or L-theanine. The evidence is modest, but both are low-risk. Professional-grade versions are in my Fullscript dispensary.

When to get help right away

If you are having thoughts of harming yourself, call or text 988 in the US. Seek urgent care for panic symptoms with chest pain or trouble breathing, because those need to be checked rather than assumed to be anxiety.


If you were told it is only anxiety, or only hormones, ask whether anyone looked at both. The answer changes the treatment, and women usually do better when it is addressed from both sides.

References

  1. Bromberger JT, Kravitz HM, Chang Y, et al. “Does risk for anxiety increase during the menopausal transition? Study of Women's Health Across the Nation.” Menopause, 2013;20(5):488-495. View source
  2. Kravitz HM, et al. “Do anxiety symptoms predict major depressive disorder in midlife women? The SWAN Mental Health Study.” Summarized by Nonacs R, MGH Center for Women's Mental Health. View source
  3. “Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.” PubMed, 2017. View source
  4. Maki PM, et al. EMAS position statement. “Management of depressive symptoms in peri- and postmenopausal women.” Maturitas, 2020;131:91-101. View source
  5. Contemporary OB/GYN. “Estrogen therapy shows mixed mental health effects in menopause” (systematic reviews presented at The Menopause Society 2025 Annual Meeting). October 25, 2025. View source
  6. Bonafide. “5th Annual State of Menopause Study.” 2025 (industry survey). View source